418 related articles for article (PubMed ID: 30917943)
21. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment.
Tomlins SA; Day JR; Lonigro RJ; Hovelson DH; Siddiqui J; Kunju LP; Dunn RL; Meyer S; Hodge P; Groskopf J; Wei JT; Chinnaiyan AM
Eur Urol; 2016 Jul; 70(1):45-53. PubMed ID: 25985884
[TBL] [Abstract][Full Text] [Related]
22. Prostate cancer heterogeneity: texture analysis score based on multiple magnetic resonance imaging sequences for detection, stratification and selection of lesions at time of biopsy.
Orczyk C; Villers A; Rusinek H; Lepennec V; Bazille C; Giganti F; Mikheev A; Bernaudin M; Emberton M; Fohlen A; Valable S
BJU Int; 2019 Jul; 124(1):76-86. PubMed ID: 30378238
[TBL] [Abstract][Full Text] [Related]
23. Biparametric 3T Magnetic Resonance Imaging for prostatic cancer detection in a biopsy-naïve patient population: a further improvement of PI-RADS v2?
Stanzione A; Imbriaco M; Cocozza S; Fusco F; Rusconi G; Nappi C; Mirone V; Mangiapia F; Brunetti A; Ragozzino A; Longo N
Eur J Radiol; 2016 Dec; 85(12):2269-2274. PubMed ID: 27842676
[TBL] [Abstract][Full Text] [Related]
24. When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of the currently available guidelines and proposal of a novel risk stratification tool.
Briganti A; Passoni N; Ferrari M; Capitanio U; Suardi N; Gallina A; Da Pozzo LF; Picchio M; Di Girolamo V; Salonia A; Gianolli L; Messa C; Rigatti P; Montorsi F
Eur Urol; 2010 Apr; 57(4):551-8. PubMed ID: 20034730
[TBL] [Abstract][Full Text] [Related]
25. Seminal vesicle invasion on multi-parametric magnetic resonance imaging: Correlation with histopathology.
Grivas N; Hinnen K; de Jong J; Heemsbergen W; Moonen L; Witteveen T; van der Poel H; Heijmink S
Eur J Radiol; 2018 Jan; 98():107-112. PubMed ID: 29279147
[TBL] [Abstract][Full Text] [Related]
26. MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218).
Gugliandolo SG; Pepa M; Isaksson LJ; Marvaso G; Raimondi S; Botta F; Gandini S; Ciardo D; Volpe S; Riva G; Rojas DP; Zerini D; Pricolo P; Alessi S; Petralia G; Summers PE; Mistretta FA; Luzzago S; Cattani F; De Cobelli O; Cassano E; Cremonesi M; Bellomi M; Orecchia R; Jereczek-Fossa BA
Eur Radiol; 2021 Feb; 31(2):716-728. PubMed ID: 32852590
[TBL] [Abstract][Full Text] [Related]
27. Automated multiparametric localization of prostate cancer based on B-mode, shear-wave elastography, and contrast-enhanced ultrasound radiomics.
Wildeboer RR; Mannaerts CK; van Sloun RJG; Budäus L; Tilki D; Wijkstra H; Salomon G; Mischi M
Eur Radiol; 2020 Feb; 30(2):806-815. PubMed ID: 31602512
[TBL] [Abstract][Full Text] [Related]
28. 4D perfusion CT of prostate cancer for image-guided radiotherapy planning: A proof of concept study.
Beer L; Polanec SH; Baltzer PAT; Schatzl G; Georg D; Schestak C; Dutschke A; Herrmann H; Mazal P; Brendel AK; Shariat SF; Ringl H; Helbich TH; Apfaltrer P
PLoS One; 2019; 14(12):e0225673. PubMed ID: 31856177
[TBL] [Abstract][Full Text] [Related]
29. Fusion of Magnetic Resonance Imaging and Real-Time Elastography to Visualize Prostate Cancer: A Prospective Analysis using Whole Mount Sections after Radical Prostatectomy.
Brock M; Roghmann F; Sonntag C; Sommerer F; Tian Z; Löppenberg B; Palisaar RJ; Noldus J; Hanske J; von Bodman C
Ultraschall Med; 2015 Aug; 36(4):355-61. PubMed ID: 24854132
[TBL] [Abstract][Full Text] [Related]
30. MRI-Based Radiomics Signature for the Preoperative Prediction of Extracapsular Extension of Prostate Cancer.
Ma S; Xie H; Wang H; Han C; Yang J; Lin Z; Li Y; He Q; Wang R; Cui Y; Zhang X; Wang X
J Magn Reson Imaging; 2019 Dec; 50(6):1914-1925. PubMed ID: 31062459
[TBL] [Abstract][Full Text] [Related]
31. Identifying in vivo DCE MRI markers associated with microvessel architecture and gleason grades of prostate cancer.
Singanamalli A; Rusu M; Sparks RE; Shih NN; Ziober A; Wang LP; Tomaszewski J; Rosen M; Feldman M; Madabhushi A
J Magn Reson Imaging; 2016 Jan; 43(1):149-58. PubMed ID: 26110513
[TBL] [Abstract][Full Text] [Related]
32. The clinical value of dynamic contrast-enhanced magnetic resonance imaging at 3.0T to detect prostate cancer.
Zhang X; Quan X; Lu S; Huang F; Yang J; Chan Q; Lin T
J Int Med Res; 2014 Oct; 42(5):1077-84. PubMed ID: 25091389
[TBL] [Abstract][Full Text] [Related]
33. Dynamic contrast-enhanced imaging has limited added value over T2-weighted imaging and diffusion-weighted imaging when using PI-RADSv2 for diagnosis of clinically significant prostate cancer in patients with elevated PSA.
De Visschere P; Lumen N; Ost P; Decaestecker K; Pattyn E; Villeirs G
Clin Radiol; 2017 Jan; 72(1):23-32. PubMed ID: 27726850
[TBL] [Abstract][Full Text] [Related]
34. Multiparametric MRI for prostate cancer detection: Preliminary results on quantitative analysis of dynamic contrast enhanced imaging, diffusion-weighted imaging and spectroscopy imaging.
Fusco R; Sansone M; Petrillo M; Setola SV; Granata V; Botti G; Perdonà S; Borzillo V; Muto P; Petrillo A
Magn Reson Imaging; 2016 Sep; 34(7):839-45. PubMed ID: 27071309
[TBL] [Abstract][Full Text] [Related]
35. Haralick textural features on T
Gnep K; Fargeas A; Gutiérrez-Carvajal RE; Commandeur F; Mathieu R; Ospina JD; Rolland Y; Rohou T; Vincendeau S; Hatt M; Acosta O; de Crevoisier R
J Magn Reson Imaging; 2017 Jan; 45(1):103-117. PubMed ID: 27345946
[TBL] [Abstract][Full Text] [Related]
36. DCE-MRI of the prostate using shutter-speed vs. Tofts model for tumor characterization and assessment of aggressiveness.
Hectors SJ; Besa C; Wagner M; Jajamovich GH; Haines GK; Lewis S; Tewari A; Rastinehad A; Huang W; Taouli B
J Magn Reson Imaging; 2017 Sep; 46(3):837-849. PubMed ID: 28092414
[TBL] [Abstract][Full Text] [Related]
37. Associations of Prostate-Specific Antigen, Prostate Carcinoma Tissue Gleason Score, and Androgen Receptor Expression with Bone Metastasis in Patients with Prostate Carcinoma.
Chen Y; Lin Y; Nie P; Jiang W; Liu Y; Yuan R; Li M; Zhao S; Lin H; Li P; Zhang J; Hu Z; Xu J; Zhu X
Med Sci Monit; 2017 Apr; 23():1768-1774. PubMed ID: 28400549
[TBL] [Abstract][Full Text] [Related]
38. Radiomics strategy for glioma grading using texture features from multiparametric MRI.
Tian Q; Yan LF; Zhang X; Zhang X; Hu YC; Han Y; Liu ZC; Nan HY; Sun Q; Sun YZ; Yang Y; Yu Y; Zhang J; Hu B; Xiao G; Chen P; Tian S; Xu J; Wang W; Cui GB
J Magn Reson Imaging; 2018 Dec; 48(6):1518-1528. PubMed ID: 29573085
[TBL] [Abstract][Full Text] [Related]
39. DCE-MRI texture analysis with tumor subregion partitioning for predicting Ki-67 status of estrogen receptor-positive breast cancers.
Fan M; Cheng H; Zhang P; Gao X; Zhang J; Shao G; Li L
J Magn Reson Imaging; 2018 Jul; 48(1):237-247. PubMed ID: 29219225
[TBL] [Abstract][Full Text] [Related]
40. Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer.
Druskin SC; Tosoian JJ; Young A; Collica S; Srivastava A; Ghabili K; Macura KJ; Carter HB; Partin AW; Sokoll LJ; Ross AE; Pavlovich CP
BJU Int; 2018 Apr; 121(4):619-626. PubMed ID: 29232037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]